
Tofes 17 is the authorization form Israel's four health funds issue for external medical services. It is the commercial gate that decides which foreign devices, procedures, and private providers reach Israeli patients at scale.
Tofes 17, or Form 17, is the commitment-to-pay document an Israeli health fund issues so a specialist, hospital or imaging center can treat a member without billing them privately. It matters commercially because providers, private hospitals and medical vendors depend on the funds' willingness to issue it, but its exact effect on device sales is analysis, not a measured fact.
Last updated: October 25, 2026.
What Is Tofes 17?
Tofes 17 (Hebrew: טופס 17, "Form 17"), also called a hitchayvut or commitment, is the document through which a health fund undertakes to pay a provider for a specific service. The Israeli government's Kol Zchut rights portal describes it as the fund's commitment toward the service provider to finance the medical service it gives the member. Members request it through a branch or the fund's personal online area, and each fund runs its own issuance process.
Without a Form 17, a provider may refuse to treat a member under fund coverage or bill them privately, according to the guide published by Yad L'Olim. It usually follows a referral (hafnaya) from a fund doctor. The Health Ministry also publishes standard codes for why a Form 17 request may be rejected, such as a service outside the basket, a service with a co-payment or an age limit.
Which Funds Issue Tofes 17?
Israel's four statutory health funds issue it: Clalit, Maccabi, Meuhedet and Leumit. Each has its own contracted-provider network, app workflow and approval rules. Members with supplemental plans (Shaban) generally expect broader access than the basic basket gives them.
Why Does Tofes 17 Matter to Healthcare Businesses?
Olam's reading, as analysis, is that Form 17 sits where three commercial interests meet. Private hospitals and imaging centers depend on fund commitments for patient volume, since a fund that issues fewer commitments for outside providers sends fewer patients their way. Foreign medical-device and drug companies face a similar dependency: international approvals such as CE marking or FDA clearance do not by themselves guarantee fund payment, which depends on basket inclusion and fund contracting. Domestic med-tech founders face the same question of whether a product is reimbursed, not just approved.
The funds' own economics add friction. Every commitment issued for an outside provider is spending against the fund's budget, and a fund that owns its own facilities has an incentive to route members to them. Olam has not found a published comparison of how often each fund issues or refuses external commitments, so claims that one fund is more permissive than another should be treated as unverified.
What Is Changing?
Funds have moved much of Form 17 issuance into member apps, which can speed up routine requests. Whether automated pre-authorization changes the denial rate is an open question that regulators and patient advocates raise. Supplemental insurance keeps growing, and disputes between funds and members tend to follow whenever expectations outrun the basket. Olam has not confirmed any pending Health Ministry plan to publish standard reference prices for the most common commitments.
Frequently Asked Questions
What is Tofes 17 in Israel?
It is the commitment-to-pay form that an Israeli health fund issues to a provider so that a member can receive a service without being billed privately.
Who issues Tofes 17?
The member's health fund: Clalit, Maccabi, Meuhedet or Leumit. Members usually request it through a branch or the fund's online area after getting a referral.
Do I need Tofes 17 for every specialist or test?
Often, for services outside your home clinic, such as specialists, hospital care and imaging. Procedures vary by fund, so check with your fund's app or service line.
What happens if a fund refuses to issue a Tofes 17?
The request can be rejected for reasons such as a service outside the basket, a service with a co-payment, or an age limit. Members can escalate through their fund and the Health Ministry's complaint channels.
Does Tofes 17 decide which medical devices sell in Israel?
Not directly. It is a payment commitment for a service, but funds' willingness to pay for procedures that use a device affects commercial demand. That link is analysis, not a measured effect.
Sources
Kol Zchut, Receiving a commitment form (Tofes 17) from the health fund; Yad L'Olim, Form 17 (Hitchayvut) guide.
How we report: Olam stories draw on public filings, company disclosures and named sources, checked by our editors. Read our methodology · Corrections







